##  [Two new analyses reinforce consistent efficacy of Novartis therapy Gilenya across wide range of relapsing MS patients ](/us-en/news/media-releases/two-new-analyses-reinforce-consistent-efficacy-novartis-therapy-gilenya-across-wide-range-relapsing-ms-patients-0 "Two new analyses reinforce consistent efficacy of Novartis therapy Gilenya across wide range of relapsing MS patients ") 

  May 31, 2012